ADRX Andrx

Notice is hereby given that a class action has been commenced in the United States District Court for the Southern District of Florida, on behalf of purchasers of Andrx Corp. ("ANDRX" or the "Company") (Nasdaq: ADRX) common stock during the class period between March 9, 2005 and September 5, 2005 (the "Class Period"). Stull, Stull & Brody has substantial experience representing employees who suffered losses from purchases of their employer's stock in their 401(k) plans. If you bought Andrx Corp' stock through your Andrx Corp. retirement account and have information or would like to learn more about these claims, please contact us. The Complaint charges defendants with violations of the Securities Exchange Act of 1934. The Complaint alleges that defendants were aware of and failed to disclose the fact that their manufacturing facilities did not comply with all applicable good manufacturing practices ("cGMP") regulations and that Andrx was facing serious regulatory sanctions as a result of its cGMP violations including a sanction that would preclude the Food and Drug Administration ("FDA") approval of Andrx' pending and future drug applications. On September 6, 2005, defendants shocked the market when they announced that the FDA had recently placed a halt on approving Andrx' s drug applications. In response to this press release, Andrx stock dropped from a closing price of $17.94 on September 5, 2005 to $14.89 on September 6, 2005 on heavy trading volume. If you purchased common stock of Andrx Corp. during the period March 9, 2005 to September 5, 2005, you may, no later than December 12, 2005, request that the Court appoint you as lead plaintiff. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Under certain circumstances, one or more class members may together serve as "lead plaintiff." Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain Stull, Stull & Brody, or other counsel of your choice, to serve as your counsel in this action. Stull, Stull & Brody has litigated many class actions for violations of securities laws in federal courts over the past 30 years and has obtained court approval of substantial settlements on numerous occasions. Stull, Stull & Brody maintains offices in both New York and Los Angeles. If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Tzivia Brody, Esq. at Stull, Stull & Brody by e-mail at SSBNY@aol.com, by calling toll-free 1-800-337-4983, or by fax at 212/490-2022, or by writing to Stull, Stull & Brody, 6 East 45th Street, New York, NY 10017. You can also visit our website at www.ssbny.com.